Form 4 for DFTX Definium Therapeutics, Inc.
Accepted 2022-10-27 00:00:00 ET · period of report 2022-10-25 · accession 0000899243-22-034336 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-10-27 | 2022-10-25+ | DFTX | Karlin Dan | Chief Medical Off | S - Sale | $2.91 | -1,185 | 265.3K | -0.4% | -$3,452 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-10-25 | S | D | 541 | $2.81 | 265,937 | D | — | — | (F2) The Common Shares were sold in multiple transactions, all at a price of $3.83 CAD Dollars. This represents the price in United States Dollars using the conversion rate on October 25, 2022. |
| 2 | Common | Common Shares | 2022-10-27 | S | D | 644 | $3.00 | 265,293 | D | — | — | (F4) The Common Shares were sold in multiple transactions, all at a price of $4.07 CAD Dollars. This represents the price in United States Dollars using the conversion rate on October 27, 2022. |